A case of anti-Mi-2 antibody-positive dermatomyositis associated with malignant lymphoma

被引:0
|
作者
Ohashi, Masafumi [1 ]
Takagi, Hajime [1 ]
Hayakawa, Masaya [2 ]
Hamaguchi, Yasuhito [3 ]
Seishima, Mariko [4 ]
机构
[1] Ogaki Municipal Hosp, Dept Dermatol, Minaminokawa 4-86, Ogaki, Gifu 5011194, Japan
[2] Ogaki Municipal Hosp, Dept Hematol, Ogaki, Japan
[3] Kanazawa Univ, Dept Mol Pathol Skin, Grad Sch Med, Kanazawa, Ishikawa, Japan
[4] Gifu Univ, Dept Dermatol, Grad Sch Med, Gifu, Japan
关键词
Anti-Mi-2; antibody; anti-transcriptional intermediary factor 1 gamma antibody; dermatomyositis; malignant lymphoma; myositis-specific autoantibody; AUTOANTIBODIES; MYOSITIS; POLYMYOSITIS;
D O I
10.1080/24725625.2018.1507277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dermatomyositis is a systemic idiopathic inflammatory myopathy often associated with internal malignancy and/or interstitial lung disease. The clinical phenotype of dermatomyositis depends on the presence of myositis-specific autoantibodies in the serum. We present a case of a 64-year-old woman who developed symmetrical muscle weakness. Systemic PET-CT showed an accumulation of fluorine 18 fluorodeoxyglucose in the mesenteric and para-aortic lymph nodes, indicating their swelling. Biopsy specimen with peritonectomy showed follicular lymphoma (Grade 2, clinical stage II). Chemotherapy and systemic corticosteroids improved clinical manifestations. Her serum was later found to be positive for anti-Mi-2 antibody by enzyme-linked immunosorbent assay and immunoprecipitation. The association of anti-Mi-2 antibody positive dermatomyositis with malignant lymphoma is rare and has seldom been reported in the English literature.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 50 条
  • [41] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [42] Plasma exchange for anti-MDA5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung disease: A case report and literature review
    Lu, Ci
    Xu, Cheng
    Zhu, Xiaoying
    Han, Yongmei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [43] Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses
    Yang, Q.
    Lyu, K.
    Li, J.
    Zhang, P.
    Guan, W.
    Zhang, L.
    Han, L.
    Liu, S.
    Li, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (02) : 304 - 308
  • [44] Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis
    Horai, Yoshiro
    Koga, Tomohiro
    Fujikawa, Keita
    Takatani, Ayuko
    Nishino, Ayako
    Nakashima, Yoshikazu
    Suzuki, Takahisa
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Ida, Hiroaki
    Kakugawa, Tomoyuki
    Sakamoto, Noriho
    Ishimatsu, Yuji
    Mukae, Hiroshi
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Kuwana, Masataka
    Origuchi, Tomoki
    Kohno, Shigeru
    Kawakami, Atsushi
    MODERN RHEUMATOLOGY, 2015, 25 (01) : 85 - 89
  • [45] Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy
    Ge, Yongpeng
    Li, Shanshan
    Tian, Xiaolan
    He, Linrong
    Lu, Xin
    Wang, Guochun
    CLINICAL RHEUMATOLOGY, 2021, 40 (06) : 2311 - 2317
  • [46] Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis
    Maria Isabel Cardoso dos Passos Carvalho
    Samuel Katsuyuki Shinjo
    Advances in Rheumatology, 59
  • [47] Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission A case report
    Endo, Yushiro
    Koga, Tomohiro
    Ishida, Midori
    Fujita, Yuya
    Tsuji, Sosuke
    Takatani, Ayuko
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Igawa, Takashi
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Kuwana, Masataka
    Hosono, Yuji
    Mimori, Tsuneyo
    Kawakami, Atsushi
    MEDICINE, 2018, 97 (26)
  • [48] Tension Pneumomediastinum in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease: A Case Report and Literature Review
    Okabayashi, Hiroko
    Nakashima, Seiya
    Fujino, Kosuke
    Imai, Miyu
    Hamada, Shohei
    Masunaga, Aiko
    Ichiyasu, Hidenori
    Suzuki, Makoto
    Sakagami, Takuro
    INTERNAL MEDICINE, 2024, 63 (23) : 3221 - 3226
  • [49] Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
    Tomita, Natsuo
    Tamechika, Shin-Ya
    Kawakita, Daisuke
    Saito, Kenta
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
  • [50] Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients
    Fujiki, Youhei
    Kotani, Takuya
    Isoda, Kentaro
    Ishida, Takaaki
    Shoda, Takeshi
    Yoshida, Shuzo
    Takeuchi, Tohru
    Makino, Shigeki
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 133 - 140